Skip to main content
Premium Trial:

Request an Annual Quote

Lilly to Use Exosome Diagnostics' Nucleic Acid Extraction Kit for Biomarker Research

Premium

Exosome Diagnostics this week announced that it has signed a deal to collaborate with Eli Lilly on mRNA and microRNA biomarker discovery and validation.

Under the arrangement, Lilly will have early access to Exosome's EXO50 nucleic acid extraction kit, which isolates both mRNA and microRNA, and can distinguish between exosomal microRNA and protein-complexed microRNA. It will use the technology to identify gene mutations and expression levels in blood that may be correlated with drug response and disease recurrence.

Financial terms of the arrangement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.